<DOC>
	<DOCNO>NCT02056574</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , single-dose study investigate safety efficacy NA-1 patient subarachnoid hemorrhage ( SAH ) undergo endovascular repair rupture intracranial aneurysm . Up 300 male female patient SAH undergo endovascular repair rupture intracranial aneurysm dose 2.60 mg/kg NA-1 placebo 10 minute intravenous infusion completion endovascular procedure Day 1 study period . Subjects undergo interim procedure Day 2-4 , Day 30-45 , end-of-study procedure Day 90 .</brief_summary>
	<brief_title>Safety Efficacy Study Single Dose NA-1 Patients Undergoing Endovascular Repair Ruptured Aneurysms</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<mesh_term>Rupture</mesh_term>
	<criteria>1 . A diagnosis rupture brain aneurysm deem suitable repair neuroendovascular technique involve intraluminal occlusion detachable platinum coil , neuroendovascular technique balloonassisted coiling , stenting , flow diversion . 2 . Patient Grade IIIV WFNS grade scale SAH . 3 . Male female minimum age 18 year day enrolment . 4 . Female subject childbearing potential : Negative pregnancy test . 5 . Nonsurgically sterile male male partner childbearing potential must willing use condom spermicide 3 month completion dose . 6 . Body weight less equal 180 kg . 7 . Vital sign admission : Blood pressure 80180 mm Hg systolic/50100 mm Hg diastolic ; Body temperature ≤ 38.5C . 8 . Informed consent availability subject entire study period willingness subject adhere protocol requirement . 1 . Prior SAH within 6 month presentation . 2 . Dissecting mycotic brain aneurysm . 3 . Planned endovascular vessel sacrifice primary modality aneurysm treatment . 4 . Known history lifethreatening allergic reaction medication . 5 . Chronic renal disease define baseline serum creatinine &gt; 150 µmol/L . 6 . Women pregnant , positive urine blood ( βhCG ) pregnancy test . 7 . Women breastfeed . 8 . Any clinically significant psychiatric psychological disease , would preclude patient complete protocol . 9 . Premorbid ( estimate ) modify Rankin scale score &gt; 1 . 10 . Previous major stroke . 11 . Patients know HIV infection . 12 . Participation clinical trial investigational drug within 30 day precede study . 13 . Previous participation ENACT trial ( e.g , treat prior aneurysm ) , participation another trial involve NA1 prior receipt NA1 . 14 . Any medical condition site investigator deems would put patient excessive risk participation study expect life expectancy le 1 year would result inability collect clinical outcome 90 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Endovascular repair</keyword>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>Ruptured intracranial aneurysm</keyword>
	<keyword>Stroke</keyword>
	<keyword>Coiling</keyword>
	<keyword>NA-1</keyword>
</DOC>